These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22726884)

  • 1. Image-guided robotic stereotactic radiation therapy with fiducial-free tumor tracking for lung cancer.
    Bibault JE; Prevost B; Dansin E; Mirabel X; Lacornerie T; Lartigau E
    Radiat Oncol; 2012 Jun; 7():102. PubMed ID: 22726884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer.
    Temming S; Kocher M; Stoelben E; Hagmeyer L; Chang DH; Frank K; Hekmat K; Wolf J; Baus WW; Semrau R; Baues C; Marnitz S
    Strahlenther Onkol; 2018 Feb; 194(2):91-97. PubMed ID: 28812120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy.
    Kelley KD; Benninghoff DL; Stein JS; Li JZ; Byrnes RT; Potters L; Knisely JP; Zinkin HD
    Radiat Oncol; 2015 May; 10():120. PubMed ID: 26018408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CyberKnife radiosurgery for stage I lung cancer: results at 36 months.
    Brown WT; Wu X; Fayad F; Fowler JF; Amendola BE; García S; Han H; de la Zerda A; Bossart E; Huang Z; Schwade JG
    Clin Lung Cancer; 2007 Sep; 8(8):488-92. PubMed ID: 17922973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CyberKnife Xsight versus fiducial-based target-tracking: a novel 3D dosimetric comparison in a dynamic phantom.
    Klein TJ; Gill S; Ebert MA; Grogan G; Smith W; Alkhatib Z; Geraghty J; Scott AJD; Brown A; Rowshanfarzad P
    Radiat Oncol; 2022 Sep; 17(1):154. PubMed ID: 36076249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of robotic stereotactic radiotherapy to peripheral stage I non-small cell lung cancer with curative intent.
    Brown WT; Wu X; Fayad F; Fowler JF; García S; Monterroso MI; de la Zerda A; Schwade JG
    Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):623-31. PubMed ID: 19682875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation--CyberKnife.
    Brown WT; Wu X; Amendola B; Perman M; Han H; Fayad F; Garcia S; Lewin A; Abitbol A; de la Zerda A; Schwade JG
    Cancer J; 2007; 13(2):87-94. PubMed ID: 17476136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer.
    Collins BT; Vahdat S; Erickson K; Collins SP; Suy S; Yu X; Zhang Y; Subramaniam D; Reichner CA; Sarikaya I; Esposito G; Yousefi S; Jamis-Dow C; Banovac F; Anderson ED
    J Hematol Oncol; 2009 Jan; 2():1. PubMed ID: 19149899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verification of Accuracy of CyberKnife Tumor-tracking Radiation Therapy Using Patient-specific Lung Phantoms.
    Jung J; Song SY; Yoon SM; Kwak J; Yoon K; Choi W; Jeong SY; Choi EK; Cho B
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):745-53. PubMed ID: 25936598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment.
    Vahdat S; Oermann EK; Collins SP; Yu X; Abedalthagafi M; Debrito P; Suy S; Yousefi S; Gutierrez CJ; Chang T; Banovac F; Anderson ED; Esposito G; Collins BT
    J Hematol Oncol; 2010 Feb; 3():6. PubMed ID: 20132557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excellent Cancer Outcomes Following Patient-adapted Robotic Lung SBRT But a Case for Caution in Idiopathic Pulmonary Fibrosis.
    Bahig H; Filion E; Vu T; Roberge D; Lambert L; Bouchard M; Lavoie C; Doucet R; Nadeau DB; Chalaoui J; Campeau MP
    Technol Cancer Res Treat; 2015 Dec; 14(6):667-76. PubMed ID: 24988054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
    Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP
    Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early results of CyberKnife image-guided robotic stereotactic radiosurgery for treatment of lung tumors.
    Brown WT; Wu X; Wen BC; Fowler JF; Fayad F; Amendola BE; García S; De La Zerda A; Huang Z; Schwade JG
    Comput Aided Surg; 2007 Sep; 12(5):253-61. PubMed ID: 17957532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust localization of poorly visible tumor in fiducial free stereotactic body radiation therapy.
    Xu D; Descovich M; Liu H; Sheng K
    Radiother Oncol; 2024 Nov; 200():110514. PubMed ID: 39214256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome.
    van der Voort van Zyp NC; Prévost JB; Hoogeman MS; Praag J; van der Holt B; Levendag PC; van Klaveren RJ; Pattynama P; Nuyttens JJ
    Radiother Oncol; 2009 Jun; 91(3):296-300. PubMed ID: 19297048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved respiratory motion tracking through a novel fiducial marker placement guidance system during electromagnetic navigational bronchoscopy (ENB).
    Stowe H; Ogake S; Sharma S; Kelly S; McDonald M; Stanley K; Walker P; Arastu H; Granadillo CA; Bowling M; Ju A
    Radiat Oncol; 2019 Jul; 14(1):124. PubMed ID: 31296231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).
    Dunlap NE; Larner JM; Read PW; Kozower BD; Lau CL; Sheng K; Jones DR
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):583-9. PubMed ID: 20478576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive parameters of CyberKnife fiducial-less (XSight Lung) applicability for treatment of early non-small cell lung cancer: a single-center experience.
    Bahig H; Campeau MP; Vu T; Doucet R; Béliveau Nadeau D; Fortin B; Roberge D; Lambert L; Carrier JF; Filion E
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):583-9. PubMed ID: 23953636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target margin design for real-time lung tumor tracking stereotactic body radiation therapy using CyberKnife Xsight Lung Tracking System.
    Yang ZY; Chang Y; Liu HY; Liu G; Li Q
    Sci Rep; 2017 Sep; 7(1):10826. PubMed ID: 28883654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system.
    Katoh N; Soda I; Tamamura H; Takahashi S; Uchinami Y; Ishiyama H; Ota K; Inoue T; Onimaru R; Shibuya K; Hayakawa K; Shirato H
    Radiat Oncol; 2017 Jan; 12(1):3. PubMed ID: 28057036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.